These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1703602)

  • 1. Clinical studies with the potassium channel activator cromakalim in normotensive and hypertensive subjects.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):790-5. PubMed ID: 1703602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel stimulation in normal subjects and in patients with essential hypertension: an acute study with cromakalim (BRL 34915).
    Singer DR; Markandu ND; Miller MA; Sugden AL; MacGregor GA
    J Hypertens Suppl; 1989 Dec; 7(6):S294-5. PubMed ID: 2698941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
    Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
    Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of renin secretion by potassium-channel activation with cromakalim.
    Ferrier CP; Kurtz A; Lehner P; Shaw SG; Pusterla C; Saxenhofer H; Weidmann P
    Eur J Clin Pharmacol; 1989; 36(5):443-7. PubMed ID: 2666140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
    Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the potassium channel activator, cromakalim, on arterial and cardiac responses to norepinephrine, angiotensin II, and isoproterenol in normotensive men.
    von Nguyen P; Holliwell DL; Davis A; Tasker TC; Leenen FH
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):797-806. PubMed ID: 1725890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular effects of the K(+)-channel activator cromakalim in man.
    Lijnen P; Fagard R; Staessen J; Weiping T; Moerman E; Amery A
    Eur J Clin Pharmacol; 1989; 37(6):609-11. PubMed ID: 2693118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
    Pratz J; Mondot S; Montier F; Cavero I
    J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of cromakalim (BRL 34915) in healthy volunteers.
    Fox JS; Whitehead EM; Shanks RG
    Br J Clin Pharmacol; 1991 Jul; 32(1):45-9. PubMed ID: 1888641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertension.
    Lebel M; Grose JH; Lacourcière Y
    Am J Hypertens; 1991 Sep; 4(9):740-4. PubMed ID: 1834087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antihypertensive property of NIP-121, a novel potassium channel opener in rats.
    Masuda Y; Arakawa C; Yokoyama T; Shigenobu K; Tanaka S
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):190-7. PubMed ID: 1717778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
    Lantelme P; Lo M; Sassard J
    Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in potassium content and membrane potassium channels in circulating cells from normal volunteers treated with cromakalim.
    Lijnen P; Weiping T; Fagard R; Staessen J; Amery A
    J Hypertens; 1989 May; 7(5):403-7. PubMed ID: 2768826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
    Kawahara J; Jinno Y; Endo M; Izumi H; Takeuchi A; Izawa T
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):814-9. PubMed ID: 9234664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term monotherapy with the potassium channel activator BRL 34915 on endocrine sodium regulation in essential hypertension.
    Lebel M; Grose JH; Lacourcière Y
    Am J Hypertens; 1989 Apr; 2(4):256-8. PubMed ID: 2523222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacology of Ro 31-6930, a new potassium channel opener.
    Paciorek PM; Burden DT; Burke YM; Cowlrick IS; Perkins RS; Taylor JC; Waterfall JF
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):188-97. PubMed ID: 1689412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    Nakajima T; Shinohara T; Yaoka O; Fukunari A; Shinagawa K; Aoki K; Katoh A; Yamanaka T; Setoguchi M; Tahara T
    J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential small arteriolar vasodilatation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive rats.
    Struijker Boudier HA; Messing MW; van Essen H
    Eur J Pharmacol; 1992 Jul; 218(1):191-3. PubMed ID: 1397031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.